Validation of MCL1 inhibition and combinatorial therapy for elimination of osteosarcoma lung metastasis episode artwork

EPISODE · Aug 10, 2026 · 1H 1M

Validation of MCL1 inhibition and combinatorial therapy for elimination of osteosarcoma lung metastasis

from MIB Agents OsteoBites and osTEAo · host MIB Agents Osteosarcoma

Dr. Alexander Davies discusses his OutSmarting Osteosarcoma-funded work on the validation of MCL1 inhibition and combinatorial therapy for elimination of osteosarcoma lung metastasis, funded Because of Matthew, in partnership with Fishin' for the Cure.

Episode metadata supplied by the publisher feed · Published Aug 10, 2026

Embed this episode

NOW PLAYING

Validation of MCL1 inhibition and combinatorial therapy for elimination of osteosarcoma lung metastasis

0:00 1:01:54

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of MIB Agents OsteoBites and osTEAo?

This episode is 1 hour and 1 minute long.

When was this MIB Agents OsteoBites and osTEAo episode published?

This episode was published on August 10, 2026.

Can I download this MIB Agents OsteoBites and osTEAo episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!